Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
New Zealand Direct-to-Patient Market: By Type, By Therapeutics, By Model, and Other DtP Models), and Country
New Zealand Direct-to-Patient Market: By Type, By Therapeutics, By Model, and Other DtP Models), and Country
New Zealand Direct-to-Patient Market is expected to have significant growth during the forecast years (2024-2030). The DTP market relates to the concept of the distribution model of pharmaceuticals, healthcare devices, or medical services directly to the patient without the interface between traditional channels, e.g., a pharmacy or a healthcare professional. That usually includes either an online platform, a platform offering telehealth services, or some sort of specialized logistics network to ensure that the patient gets their medicines or medicinal products right at the comfort of their homes. The DTP model has gained increased favor as there is a growing need for convenience, especially in the management of chronic diseases, remote areas, and during situations like the COVID-19 pandemic.
In New Zealand, the Direct-to-Patient market has been growing steadily, driven by an aging population, increased prevalence of chronic diseases, and advancements in digital health technologies. For instance, as per the article published in the gerontologist over the next 20 years, the older population in New Zealand is predicted to double to 1.30 million due to ongoing increases in life expectancy. Additionally, the integration of telemedicine with DTP services can enhance patient engagement and adherence to treatment plans, creating new opportunities for market growth. However, the DTP model faces regulatory hurdles, particularly around the direct delivery of prescription medications and the need to comply with stringent pharmaceutical regulations.
The New Zealand government has been very instrumental in the development of the Direct-to-Patient market, investing resources in telehealth services and supporting policies that guarantee remote healthcare delivery. In response to the COVID-19 pandemic, the New Zealand government rapidly expanded telehealth services, allowing healthcare to be delivered to patients from a distance. It was accompanied by temporary regulatory relaxations that allowed for the delivery of prescription medications directly to patients' homes. The Ministry of Health reported that during the pandemic, there was an increase in telehealth consultations by more than 60%, evidence of demand and the facilitating role of government.
|
Report Benchmarks |
Details |
|
By Type |
|
|
By Therapeutics |
|
|
By Model |
|
Download Free Sample Report
The DTP market involves delivering healthcare products and services directly to patients, bypassing traditional intermediaries like pharmacies or healthcare providers.
The growth is driven by factors such as the aging population, government support for telehealth, and the country's robust digital health infrastructure.
Key challenges include regulatory hurdles, logistics issues, and data privacy concerns.
The government has supported the market through investments in telehealth, regulatory relaxations during the COVID-19 pandemic, and policies that encourage remote healthcare delivery.
There are opportunities to expand services in rural areas and integrate telemedicine with DTP services to enhance patient care.
1. Executive Summary
2. New Zealand Direct-to-Patient (DTP) Market Introduction
2.1. New Zealand Direct-to-Patient (DTP) Market - Taxonomy
2.2. New Zealand Direct-to-Patient (DTP) Market - Definitions
2.2.1. By Type
2.2.2. By Therapeutics
2.2.3. By Model
2.2.4. By Region
3. New Zealand Direct-to-Patient (DTP) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. New Zealand Direct-to-Patient (DTP) Market Analysis, 2018-2022 and Forecast 2023-2029
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. New Zealand Direct-to-Patient (DTP) Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. DTP Marketing
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Dtp Health Services
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. DTP Clinical Trials
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. DTP Logistics
5.4.1.DTP Logistics Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. New Zealand Direct-to-Patient (DTP) Market By Therapeutics, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Respiratory Diseases
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Oncology
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Infectious Diseases
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Dermatology
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other Therapeutics
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. New Zealand Direct-to-Patient (DTP) Market By Model, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Site-to-Patient
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Hybrid Model
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Direct-From-Patient (DfP)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Other DtP Models
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Competition Landscape
8.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)
8.2.1.Teladoc Health, Inc.
8.2.2.Doctor on Demand
8.2.3.Nurx
8.2.4.Specialists On Call Inc.
8.2.5.Babylon Health
8.2.6.Dictum Health
8.2.7.Doctor Anywhere Pte. Ltd.
8.2.8.Practo Technologies Private Limited
8.2.9.CitiusTech Inc.
8.2.10.Hims & Hers Health, Inc.
8.2.11.Health Tap
8.2.12.Marken
8.2.13.HealthPartners, Inc.
9. Research Methodology
10. Appendix and Abbreviations
Key Market Players
• Teladoc Health, Inc.
• Doctor on Demand
• Nurx
• Specialists On Call Inc.
• Babylon Health
• Dictum Health
• Doctor Anywhere Pte. Ltd.
• Practo Technologies Private Limited
• CitiusTech Inc.
• Hims & Hers Health, Inc.
• Health Tap
• Marken
• HealthPartners, Inc.
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.